A phase I study of CX-4945 administered orally twice daily to patients with advanced basal cell carcinoma.

Zeynep Eroglu,Charles Lance Cowey,John Soong,Daniel McCormick,Phoebe Fan,Jimmy Chen,Mohamed Elgendy,Sekwon Jang,Anne Lynn S. Chang

A phase I study of CX-4945 administered orally twice daily to patients with advanced basal cell carcinoma.

2020

Zeynep Eroglu
Charles Lance Cowey
John Soong
Daniel McCormick
Phoebe Fan
Jimmy Chen
Mohamed Elgendy
Sekwon Jang
Anne Lynn S. Chang

TPS10080Background: Smoothened inhibitors (SMOi) targeting the Hedgehog (Hh) pathway have been approved for the treatment of patients with locally advanced Basal Cell Carcinoma (laBCC) or metastati...

Keywords:

Internal medicine
phase i study
Gastroenterology
Pathology
Medicine
Basal cell carcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations